Standout Papers
Immediate Impact
1 from Science/Nature 45 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Chenyang Guo being referenced
Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization
2016
Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Chenyang Guo | 168 | 76 | 60 | 86 | 83 | 36 | 447 | |
| Da‐Hee Jeong | 106 | 71 | 55 | 98 | 135 | 31 | 499 | |
| Binghang Li | 104 | 79 | 62 | 146 | 145 | 40 | 485 | |
| Sang Jong Park | 129 | 135 | 44 | 103 | 84 | 35 | 475 | |
| Minyue Zhang | 69 | 46 | 32 | 91 | 182 | 25 | 503 | |
| Liping Liu | 70 | 85 | 51 | 124 | 157 | 32 | 445 | |
| Juliette Joubert‐Zakeyh | 57 | 72 | 37 | 79 | 144 | 19 | 409 | |
| Li Jiang | 108 | 174 | 30 | 59 | 162 | 22 | 448 | |
| Qamar Jamal | 55 | 37 | 24 | 76 | 152 | 30 | 486 | |
| Kui Yang | 78 | 67 | 49 | 101 | 126 | 31 | 507 | |
| Ying Ran | 79 | 58 | 26 | 96 | 168 | 23 | 395 |
All Works
Login with ORCID to disown or claim papers
Loading papers...